Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
B1037 AlvelestatTarget: NESummary: NE inhibitor
-
A8363 ArgatrobanSummary: Thrombin mediated fibrinogen cleavage inhibitor
-
A8381 BIBR-1048Summary: Thrombin inhibitor
-
A8621 Bestatin hydrochlorideTarget: AminopeptidasesSummary: Inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
-
A8650 SaxagliptinTarget: DPP-4Summary: Selective DPP4 inhibitor
-
B3232 Z-IETD-FMK12 CitationTarget: CaspasesSummary: Caspase-8 inhibitor
-
B3233 Z-LEHD-FMK8 CitationTarget: CaspasesSummary: Irreversible Caspase-9 inhibitor.
-
A8190 Semagacestat (LY450139)Summary: γ-secretase inhibitor
-
A8200 DAPT (GSI-IX)6 CitationSummary: γ-secretase inhibitor,potent and specific
-
A4005 RO49290971 CitationSummary: γ secretase inhibitor